 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Venture Visionary Partners LLC trimmed its holdings in shares of Novartis AG (NYSE:NVS  Free Report) by 6.1% in the 2nd quarter, according to the company in its most recent 13F filing with the...

Venture Visionary Partners LLC Reduces Position in Novartis AG (NYSE:NVS)

Tompkins Financial Corp trimmed its position in Novartis AG (NYSE:NVS  Free Report) by 12.6% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 2,310 shares of the...

Novartis AG (NYSE:NVS) Shares Sold by Tompkins Financial Corp

Atlantic Union Bankshares Corp decreased its holdings in shares of Novartis AG (NYSE:NVS  Free Report) by 3.4% in the 2nd quarter, Holdings Channel.com reports. The firm owned 22,711 shares of...

Atlantic Union Bankshares Corp Reduces Stake in Novartis AG (NYSE:NVS)

Bangor Savings Bank lifted its stake in Novartis AG (NYSE:NVS  Free Report) by 6.4% in the second quarter, according to the company in its most recent disclosure with the Securities and...

Bangor Savings Bank Has $800,000 Position in Novartis AG (NYSE:NVS)

Physicians Financial Services Inc. cut its position in Novartis AG (NYSE:NVS  Free Report) by 0.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange...

Physicians Financial Services Inc. Decreases Stock Position in Novartis AG (NYSE:NVS)

Scinai s NanoAbs downregulated key molecular markers overexpressed in plaque psoriasis Stratum corneum regained normal appearance in laboratory 3D skin model Results from ex-vivo study...

Scinai Immunotherapeutics Innovative Plaque Psoriasis Treatment Shows Encouraging Preclinical Results

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Novartis price target raised to CHF 115 from CHF 106 at BofA

Investors in Novartis (NVS) saw new options begin trading today, for the January 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value...

NVS January 2026 Options Begin Trading

Investors in Novartis (NVS) saw new options become available this week, for the September 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the NVS options...

Interesting NVS Put And Call Options For September 15th

Novartis AG (NYSE:NVS  Free Report)  Equities research analysts at Zacks Research lifted their Q3 2023 earnings per share (EPS) estimates for shares of Novartis in a research note...

Analysts Issue Forecasts for Novartis AG's Q3 2023 Earnings (NYSE:NVS)

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Watchers	6,293
52-Wk Low	$74.09
52-Wk High	$105.61

Market Cap	$209.18B
Volume (M)	792,852.00
52-Wk High	$105.61
52-Wk Low	$74.09

NVS Novartis AG

About

Feed

News

Sentiment

Earnings

Fundamentals